Palleiko Benjamin L 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Palleiko Benjamin L（CIK 1366244）在 1 家公司共报告 39 笔 SEC Form 4 内部人交易（最近一笔 2026-06-11）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-06-11 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF EXECUTIVE OFFICER | 卖出 | 479,989 | $0 |
| 2026-05-26 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF EXECUTIVE OFFICER | 买入 | 23,250 | $0 |
| 2026-05-26 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF EXECUTIVE OFFICER | 卖出 | 10,926 | $292,598 |
| 2026-05-19 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF EXECUTIVE OFFICER | 买入 | 2,419 | $0 |
| 2026-05-19 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF EXECUTIVE OFFICER | 卖出 | 1,129 | $30,212 |
| 2026-05-13 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF EXECUTIVE OFFICER | 买入 | 7,120 | $0 |
| 2026-05-13 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF EXECUTIVE OFFICER | 卖出 | 3,322 | $88,731 |
| 2026-04-20 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF EXECUTIVE OFFICER | 买入 | 20,312 | $0 |
| 2026-04-20 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF EXECUTIVE OFFICER | 卖出 | 9,550 | $193,101 |
| 2026-03-10 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF EXECUTIVE OFFICER | 买入 | 15,625 | $0 |
| 2026-03-10 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF EXECUTIVE OFFICER | 卖出 | 6,693 | $107,623 |
| 2026-02-24 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF EXECUTIVE OFFICER | 卖出 | 10,034 | $156,229 |
| 2026-02-24 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF EXECUTIVE OFFICER | 买入 | 23,250 | $0 |
| 2026-02-19 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF EXECUTIVE OFFICER | 买入 | 2,419 | $0 |
| 2026-02-19 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF EXECUTIVE OFFICER | 卖出 | 1,038 | $15,570 |
| 2026-02-13 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF EXECUTIVE OFFICER | 买入 | 7,120 | $0 |
| 2026-02-13 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF EXECUTIVE OFFICER | 卖出 | 3,354 | $52,658 |
| 2025-12-09 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF EXECUTIVE OFFICER | 卖出 | 7,294 | $120,424 |
| 2025-12-09 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF EXECUTIVE OFFICER | 买入 | 15,625 | $0 |
| 2025-11-26 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF EXECUTIVE OFFICER | 买入 | 23,250 | $0 |
| 2025-11-26 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF EXECUTIVE OFFICER | 卖出 | 10,940 | $147,143 |
| 2025-11-19 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF EXECUTIVE OFFICER | 买入 | 9,364 | $0 |
| 2025-11-19 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF EXECUTIVE OFFICER | 卖出 | 4,466 | $64,668 |
| 2025-11-13 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF EXECUTIVE OFFICER | 卖出 | 3,328 | $38,438 |
| 2025-11-13 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF EXECUTIVE OFFICER | 买入 | 7,120 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-06-11